Weijian Zhou
-
- Cancer-related molecular mechanisms research 2
-
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Galectins and Cancer Biology 2
-
- Ferroptosis and cancer prognosis 5
-
- Cell Adhesion Molecules Research 2
-
- Gout, Hyperuricemia, Uric Acid 2
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Heliyon (1 paper)Radiocarbon (1 paper)
- Partner nations
- China
In The Last Decade
Weijian Zhou
18 papers receiving 241 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 79
- Rheumatology 32
- Molecular Biology 102
- Immunology 28
- Oncology 36
Countries citing papers authored by Weijian Zhou
This map shows the geographic impact of Weijian Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijian Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijian Zhou more than expected).
Fields of papers citing papers by Weijian Zhou
This network shows the impact of papers produced by Weijian Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijian Zhou. The network helps show where Weijian Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weijian Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 21 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 2 | |
| 12 | 2022 | 19 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 8 | |
| 15 | 2021 | 48 | |
| 16 | 2020 | 1 | |
| 17 | 2020 | 22 | |
| 18 | 2020 | 10 | |
| 19 | 2018 | 12 | |
| 20 | 2017 | 39 |
About Weijian Zhou
Weijian Zhou is a scholar working on Critical Care and Intensive Care Medicine, Immunology and Allergy and Nephrology, having authored 21 papers that have together received 245 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), Cell Adhesion Molecules Research (2 papers), Gout, Hyperuricemia, Uric Acid (2 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Cancer Research (79 citations), Rheumatology (32 citations) and Molecular Biology (102 citations). Weijian Zhou has collaborated with scholars based in China. Frequent co-authors include Xu Cai, Zhizhong Ye, Chaoying Liu, Huiyu Wang, Linmin Li, Guangping Zeng, Ling‐Guo Meng, Jie Mei, Rongsheng Wang and Xuejing Yang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Heliyon and Radiocarbon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.